Category: Invenis Biotherapies

InVenis Biotherapies receives support from ARSLA for the development of its groundbreaking ALS biotherapy
InVenis Biotherapies takes a leading role in a major national RHU project to transform the treatment of Amyotrophic Lateral Sclerosis (ALS)
InVenis Biotherapies is laureate of i-Lab 2022
InVenis Biotherapies receives support from the Lille University Foundation
InVenis Biotherapies receives support from BPI France through a French Tech Emergence Grant